These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 4411652)
1. A marked sex difference in the immunization capability of hamsters towards a mouse tumour. Kinsky RG Ann Immunol (Paris); 1974; 125(3):439-43. PubMed ID: 4411652 [No Abstract] [Full Text] [Related]
2. In vivo and in vitro evaluation of immune response of hamsters to immunization and transplants of autochthonous reticulum cell sarcoma. Gerber MJ; Brown ER Cancer Res; 1973 Nov; 33(11):3029-35. PubMed ID: 4583977 [No Abstract] [Full Text] [Related]
3. Radiocurability of a transplantable murine sarcoma as influenced by immune competence of the host and adjuvant active specific immunotherapy. Deneufbourg JM Strahlentherapie; 1975 Apr; 149(4):457-62. PubMed ID: 237344 [TBL] [Abstract][Full Text] [Related]
4. [Immunologic specificity of accelerated skin graft rejection with antigenic overlap in the H-2 system. Role of immune lymphocytes and antibodies]. Brondz BD Biull Eksp Biol Med; 1972 Dec; 73(12):61-5. PubMed ID: 4118605 [No Abstract] [Full Text] [Related]
5. [Rejection mechanisms of xenogeneic tumor graft in the cheek pouch of hamster (author's transl)]. Shiraishi M Fukuoka Igaku Zasshi; 1981 Oct; 72(10):575-88. PubMed ID: 7327500 [No Abstract] [Full Text] [Related]
6. Various immune reactions in hamsters after immunization with murine tumour cells and their roles in rejection. Shiraishi M; Nomoto K; Himeno K; Terasaka R Immunology; 1980 Jul; 40(3):395-401. PubMed ID: 7429534 [TBL] [Abstract][Full Text] [Related]
7. Host and tumor modifications associated with serial heterotransplantation of tumors through immunologically tolerant animals. Suciu-Foca N; Dumitrescu V; Lazar C; Nachtigal M Cancer Res; 1970 Jun; 30(6):1681-91. PubMed ID: 4394119 [No Abstract] [Full Text] [Related]
8. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey). McCoy JL; Ting RC; Morton DL; Law LW J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035 [No Abstract] [Full Text] [Related]
9. Host responses to methylcholanthrene sarcoma and sheep red blood cell skeletal implants. Boak JL; Stolier AJ; Tebbutt S Clin Oncol; 1977 Dec; 3(4):345-51. PubMed ID: 598062 [No Abstract] [Full Text] [Related]
10. Immunological aspects of resistance to the oncogenic effect of 3-methylcholanthrene in mice. Stutman O Isr J Med Sci; 1973 Mar; 9(3):217-28. PubMed ID: 4575650 [No Abstract] [Full Text] [Related]
11. Tumor rejection and immunotherapy studies with simian virus 40-induced tumors. Blakeslee JR; von Muenchhausen W; Cox HR J Med; 1973; 4(4):233-47. PubMed ID: 4358481 [No Abstract] [Full Text] [Related]
12. Fetal antigens shared as transplantation rejection antigens on chemically induced mouse and hamster sarcomas. Coggin JH; Adkinson L; Anderson NG Cancer Res; 1980 May; 40(5):1568-73. PubMed ID: 6768448 [No Abstract] [Full Text] [Related]
13. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system. Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949 [No Abstract] [Full Text] [Related]
18. Specific rejection and regression of solid tumour by tumour extract. Menon IR; Batra BK; Raveendran P Indian J Med Res; 1974 Jul; 62(7):1032-8. PubMed ID: 4435913 [No Abstract] [Full Text] [Related]
19. Influence of Vinblastine on antitumour immunity in mice. Klener P; Bubeník J; Jandejsek J Neoplasma; 1973; 20(3):239-42. PubMed ID: 4725513 [No Abstract] [Full Text] [Related]